457 related articles for article (PubMed ID: 15072798)
1. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.
Ingels F; Beck B; Oth M; Augustijns P
Int J Pharm; 2004 Apr; 274(1-2):221-32. PubMed ID: 15072798
[TBL] [Abstract][Full Text] [Related]
2. Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs.
Fossati L; Dechaume R; Hardillier E; Chevillon D; Prevost C; Bolze S; Maubon N
Int J Pharm; 2008 Aug; 360(1-2):148-55. PubMed ID: 18539418
[TBL] [Abstract][Full Text] [Related]
3. Development of simulated intestinal fluids containing nutrients as transport media in the Caco-2 cell culture model: assessment of cell viability, monolayer integrity and transport of a poorly aqueous soluble drug and a substrate of efflux mechanisms.
Lind ML; Jacobsen J; Holm R; Müllertz A
Eur J Pharm Sci; 2007 Dec; 32(4-5):261-70. PubMed ID: 17890067
[TBL] [Abstract][Full Text] [Related]
4. Bio-relevant media to assess drug permeability: sodium taurocholate and lecithin combination or crude bile?
Berginc K; Trontelj J; Kristl A
Int J Pharm; 2012 Jun; 429(1-2):22-30. PubMed ID: 22449411
[TBL] [Abstract][Full Text] [Related]
5. Impact of FaSSIF on the solubility and dissolution-/permeation rate of a poorly water-soluble compound.
Frank KJ; Westedt U; Rosenblatt KM; Hölig P; Rosenberg J; Mägerlein M; Brandl M; Fricker G
Eur J Pharm Sci; 2012 Aug; 47(1):16-20. PubMed ID: 22579958
[TBL] [Abstract][Full Text] [Related]
6. In vitro behavior of a phosphate ester prodrug of amprenavir in human intestinal fluids and in the Caco-2 system: illustration of intraluminal supersaturation.
Brouwers J; Tack J; Augustijns P
Int J Pharm; 2007 May; 336(2):302-9. PubMed ID: 17207947
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of fasted state human intestinal fluid as apical solvent system in the Caco-2 absorption model and comparison with FaSSIF.
Wuyts B; Riethorst D; Brouwers J; Tack J; Annaert P; Augustijns P
Eur J Pharm Sci; 2015 Jan; 67():126-135. PubMed ID: 25433246
[TBL] [Abstract][Full Text] [Related]
8. Biorelevant media for transport experiments in the Caco-2 model to evaluate drug absorption in the fasted and the fed state and their usefulness.
Markopoulos C; Thoenen F; Preisig D; Symillides M; Vertzoni M; Parrott N; Reppas C; Imanidis G
Eur J Pharm Biopharm; 2014 Apr; 86(3):438-48. PubMed ID: 24184673
[TBL] [Abstract][Full Text] [Related]
9. Biorelevant dissolution media as a predictive tool for glyburide a class II drug.
Wei H; Löbenberg R
Eur J Pharm Sci; 2006 Sep; 29(1):45-52. PubMed ID: 16815694
[TBL] [Abstract][Full Text] [Related]
10. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
11. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
Usansky HH; Sinko PJ
J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
[TBL] [Abstract][Full Text] [Related]
12. Simulated intestinal fluid as transport medium in the Caco-2 cell culture model.
Ingels F; Deferme S; Destexhe E; Oth M; Van den Mooter G; Augustijns P
Int J Pharm; 2002 Jan; 232(1-2):183-92. PubMed ID: 11790502
[TBL] [Abstract][Full Text] [Related]
13. The impact of protein on Caco-2 permeability of low mass balance compounds for absorption projection and efflux substrate identification.
Liu T; Chang LJ; Uss A; Chu I; Morrison RA; Wang L; Prelusky D; Cheng KC; Li C
J Pharm Biomed Anal; 2010 Apr; 51(5):1069-77. PubMed ID: 20036089
[TBL] [Abstract][Full Text] [Related]
14. Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo.
Linn M; Collnot EM; Djuric D; Hempel K; Fabian E; Kolter K; Lehr CM
Eur J Pharm Sci; 2012 Feb; 45(3):336-43. PubMed ID: 22172603
[TBL] [Abstract][Full Text] [Related]
15. Biological, pharmaceutical, and analytical considerations with respect to the transport media used in the absorption screening system, Caco-2.
Ingels FM; Augustijns PF
J Pharm Sci; 2003 Aug; 92(8):1545-58. PubMed ID: 12884242
[TBL] [Abstract][Full Text] [Related]
16. Implementation of the caco-2 cell culture model as a predictive tool for the oral absorption of drugs. In-house evaluation procedures.
Ingels F; Deferme S; Delbar N; Oth M; Augustijns P
J Pharm Belg; 2002; 57(6):153-8. PubMed ID: 12596572
[TBL] [Abstract][Full Text] [Related]
17. Prediction of human pharmacokinetics--gastrointestinal absorption.
Fagerholm U
J Pharm Pharmacol; 2007 Jul; 59(7):905-16. PubMed ID: 17637184
[TBL] [Abstract][Full Text] [Related]
18. A new topological descriptors based model for predicting intestinal epithelial transport of drugs in Caco-2 cell culture.
Marrero Ponce Y; Cabrera Pérez MA; Romero Zaldivar V; González Díaz H; Torrens F
J Pharm Pharm Sci; 2004 Jun; 7(2):186-99. PubMed ID: 15367375
[TBL] [Abstract][Full Text] [Related]
19. [Absorption of coptisine chloride and berberrubine across human intestinal epithelial by using human Caco-2 cell monolayers].
Ma L; Yang XW
Zhongguo Zhong Yao Za Zhi; 2007 Dec; 32(23):2523-7. PubMed ID: 18330249
[TBL] [Abstract][Full Text] [Related]
20. Advantage of the Dissolution/Permeation System for Estimating Oral Absorption of Drug Candidates in the Drug Discovery Stage.
Miyaji Y; Fujii Y; Takeyama S; Kawai Y; Kataoka M; Takahashi M; Yamashita S
Mol Pharm; 2016 May; 13(5):1564-74. PubMed ID: 27031624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
